100 related articles for article (PubMed ID: 18991686)
21. Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons.
Zhang Y; McLaughlin R; Goodyer C; LeBlanc A
J Cell Biol; 2002 Feb; 156(3):519-29. PubMed ID: 11815632
[TBL] [Abstract][Full Text] [Related]
22. The exosome of adipose-derived stem cells reduces β-amyloid pathology and apoptosis of neuronal cells derived from the transgenic mouse model of Alzheimer's disease.
Lee M; Ban JJ; Yang S; Im W; Kim M
Brain Res; 2018 Jul; 1691():87-93. PubMed ID: 29625119
[TBL] [Abstract][Full Text] [Related]
23. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.
Cataldo AM; Peterhoff CM; Troncoso JC; Gomez-Isla T; Hyman BT; Nixon RA
Am J Pathol; 2000 Jul; 157(1):277-86. PubMed ID: 10880397
[TBL] [Abstract][Full Text] [Related]
24. Tauroursodeoxycholic acid modulates p53-mediated apoptosis in Alzheimer's disease mutant neuroblastoma cells.
Ramalho RM; Borralho PM; Castro RE; Solá S; Steer CJ; Rodrigues CM
J Neurochem; 2006 Sep; 98(5):1610-8. PubMed ID: 16923170
[TBL] [Abstract][Full Text] [Related]
25. [Neuronal DNA damage correlates with a positive detection of c-Jun, nuclear factor kB, p53 and Par-4 transcription factors in Alzheimer's disease].
García-Ospina GP; Jímenez-Del Río M; Lopera F; Vélez-Pardo C
Rev Neurol; 2003 Jun 1-15; 36(11):1004-10. PubMed ID: 12808492
[TBL] [Abstract][Full Text] [Related]
26. RGS2 expression predicts amyloid-β sensitivity, MCI and Alzheimer's disease: genome-wide transcriptomic profiling and bioinformatics data mining.
Hadar A; Milanesi E; Squassina A; Niola P; Chillotti C; Pasmanik-Chor M; Yaron O; Martásek P; Rehavi M; Weissglas-Volkov D; Shomron N; Gozes I; Gurwitz D
Transl Psychiatry; 2016 Oct; 6(10):e909. PubMed ID: 27701409
[TBL] [Abstract][Full Text] [Related]
27. Commitment of protein p53 and amyloid-beta peptide (Aβ) in aging of human cerebellum.
Maślińska D; Laure-Kamionowska M; Szukiewicz D; Maśliński S; Księżopolska-Orłowska K
Folia Neuropathol; 2017; 55(2):161-167. PubMed ID: 28677373
[TBL] [Abstract][Full Text] [Related]
28. Sex differences in metabolic aging of the brain: insights into female susceptibility to Alzheimer's disease.
Zhao L; Mao Z; Woody SK; Brinton RD
Neurobiol Aging; 2016 Jun; 42():69-79. PubMed ID: 27143423
[TBL] [Abstract][Full Text] [Related]
29. p53 is regulated by and regulates members of the gamma-secretase complex.
Checler F; Dunys J; Pardossi-Piquard R; Alves da Costa C
Neurodegener Dis; 2010; 7(1-3):50-5. PubMed ID: 20160459
[TBL] [Abstract][Full Text] [Related]
30. A role for p53 in the beta-amyloid-mediated regulation of the lysosomal system.
Fogarty MP; McCormack RM; Noonan J; Murphy D; Gowran A; Campbell VA
Neurobiol Aging; 2010 Oct; 31(10):1774-86. PubMed ID: 19059678
[TBL] [Abstract][Full Text] [Related]
31. Cytosolic Extract of Human Adipose Stem Cells Reverses the Amyloid Beta-Induced Mitochondrial Apoptosis via P53/Foxo3a Pathway.
Liu T; Lee M; Ban JJ; Im W; Mook-Jung I; Kim M
PLoS One; 2017; 12(1):e0168859. PubMed ID: 28046000
[TBL] [Abstract][Full Text] [Related]
32. Short-term modern life-like stress exacerbates Aβ-pathology and synapse loss in 3xTg-AD mice.
Baglietto-Vargas D; Chen Y; Suh D; Ager RR; Rodriguez-Ortiz CJ; Medeiros R; Myczek K; Green KN; Baram TZ; LaFerla FM
J Neurochem; 2015 Sep; 134(5):915-26. PubMed ID: 26077803
[TBL] [Abstract][Full Text] [Related]
33. Beta-amyloid controls altered Reelin expression and processing in Alzheimer's disease.
Botella-López A; Cuchillo-Ibáñez I; Cotrufo T; Mok SS; Li QX; Barquero MS; Dierssen M; Soriano E; Sáez-Valero J
Neurobiol Dis; 2010 Mar; 37(3):682-91. PubMed ID: 20025970
[TBL] [Abstract][Full Text] [Related]
34. Aging, cortical injury and Alzheimer's disease-like pathology in the guinea pig brain.
Bates K; Vink R; Martins R; Harvey A
Neurobiol Aging; 2014 Jun; 35(6):1345-51. PubMed ID: 24360504
[TBL] [Abstract][Full Text] [Related]
35. Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.
Baker-Nigh A; Vahedi S; Davis EG; Weintraub S; Bigio EH; Klein WL; Geula C
Brain; 2015 Jun; 138(Pt 6):1722-37. PubMed ID: 25732182
[TBL] [Abstract][Full Text] [Related]
36. Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits.
Mattson MP; Chan SL
J Mol Neurosci; 2001 Oct; 17(2):205-24. PubMed ID: 11816794
[TBL] [Abstract][Full Text] [Related]
37. Synaptic Cell Adhesion Molecules in Alzheimer's Disease.
Leshchyns'ka I; Sytnyk V
Neural Plast; 2016; 2016():6427537. PubMed ID: 27242933
[TBL] [Abstract][Full Text] [Related]
38. p53-dependent SIRT6 expression protects Aβ42-induced DNA damage.
Jung ES; Choi H; Song H; Hwang YJ; Kim A; Ryu H; Mook-Jung I
Sci Rep; 2016 May; 6():25628. PubMed ID: 27156849
[TBL] [Abstract][Full Text] [Related]
39. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.
Lue LF; Kuo YM; Roher AE; Brachova L; Shen Y; Sue L; Beach T; Kurth JH; Rydel RE; Rogers J
Am J Pathol; 1999 Sep; 155(3):853-62. PubMed ID: 10487842
[TBL] [Abstract][Full Text] [Related]
40. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
